The global patient blood management market is projected to reach USD 33.89 billion by 2035, according to a new SNS Insider report. The market was valued at USD 16.52 billion in 2025, pointing to strong long-term growth as hospitals and health systems put more emphasis on improving blood use, transfusion efficiency, and patient outcomes.
The report highlights the United States as a major contributor to that expansion. The U.S. patient blood management market is expected to reach USD 10.60 billion by 2035, reflecting continued investment in structured blood management programs across healthcare settings. These programs are increasingly being used to reduce unnecessary transfusions and support more coordinated care.
Europe is also expected to remain a key regional market, with projections showing it could attain USD 9.42 billion by 2035. Growth in the region is tied to broader adoption of patient blood management strategies as well as ongoing modernization of hospital transfusion practices.
One of the main themes behind the forecast is the rising role of digital transfusion management technologies. As providers look for better monitoring, workflow control, and clinical decision support, technology is becoming a bigger part of how blood management programs are implemented. Together, expanding program adoption and digital tools are shaping the outlook for the patient blood management market over the next decade.
